Barinthus Biotherapeutics Plc ADR
(BRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,112 | -35,941 | -31,371 | -15,386 | -17,934 |
| Depreciation Amortization | 602 | 281 | 196 | 92 | 208 |
| Income taxes - deferred | -119 | -62 | -32 | -25 | N/A |
| Accounts receivable | 559 | 486 | 492 | 208 | 479 |
| Accounts payable and accrued liabilities | -3,528 | -3,414 | -1,547 | -707 | 586 |
| Other Working Capital | -7,178 | -10,185 | -9,340 | -1,857 | 1,921 |
| Other Operating Activity | 28,193 | 24,224 | 19,009 | 9,706 | 3,712 |
| Operating Cash Flow | $-32,583 | $-24,611 | $-22,593 | $-7,969 | $-11,028 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,146 | -722 | -594 | -392 | -293 |
| Net Acquisitions | -11,766 | N/A | N/A | N/A | 0 |
| Investing Cash Flow | $-12,912 | $-722 | $-594 | $-392 | $-293 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 41,241 |
| Common Stock Issued | 228,013 | 228,004 | 228,004 | 125,239 | N/A |
| Other Financing Activity | -5,271 | -5,271 | -3,884 | -3,424 | 193 |
| Financing Cash Flow | $222,742 | $222,733 | $224,120 | $121,815 | $41,434 |
| Exchange Rate Effect | -6,459 | -6,795 | -580 | -785 | 1,720 |
| Beginning Cash Position | 43,266 | 43,266 | 43,266 | 43,266 | 11,432 |
| End Cash Position | 214,054 | 233,871 | 243,619 | 155,935 | 43,266 |
| Net Cash Flow | $170,788 | $190,605 | $200,353 | $112,669 | $31,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,583 | -24,611 | -22,593 | -7,969 | -11,028 |
| Capital Expenditure | -1,146 | -722 | -594 | -392 | -293 |
| Free Cash Flow | -33,729 | -25,333 | -23,187 | -8,361 | -11,321 |